Even more intriguing was the observation that the A124T substitution was the only mutation detected in the CLDN1 gene in 1 of 169 brain lower grade glioma, and in 1 of 132 stomach adenocarcinoma cases, but not in over 900 breast cancers (The Cancer Genome Atlas datasets, [49]). Here, CLDN1 is linked to breast cancer.